PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE

по Ason, Brandon, van der Hoorn, José W. A., Chan, Joyce, Lee, Edward, Pieterman, Elsbet J., Nguyen, Kathy Khanh, Di, Mei, Shetterly, Susan, Tang, Jie, Yeh, Wen-Chen, Schwarz, Margrit, Jukema, J. Wouter, Scott, Rob, Wasserman, Scott M., Princen, Hans M. G., Jackson, Simon
Опубликовано в: J Lipid Res (2014)